For moderate to severe hypoglycemia due to diabetes, a prescription medication containing the hormone glucagon can be delivered by injection or nasal inhalation. Hypoglycemic emergencies ...

KLP Kapitalforvaltning AS purchased a new stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) in the fourth ...

Baqsimi is a nasal spray formulation of glucagon, already widely used as an injectable treatment for hypoglycaemia, which can occur when people with diabetes inadvertently take too much insulin.

Thrivent Financial for Lutherans reduced its stake in shares of Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH – Free Report) ...

Prohormone convertase 1/3 (PCSK1/3) is a key enzyme in peptide processing, giving rise to peptides such as the well-known metabolic regulator glucagon ... when delivered by intranasal and ...

Glucagon is a recognised therapy for the disorder ... 2019 as a hypoglycaemia rescue therapy for diabetics. Eli Lilly's nasal spray Baqsimi was also approved in 2019 for a similar indication.

And don't give them food or drink because they can choke. If they have a nasal or injectable version of glucagon, try giving that. If the seizure is because their blood sugar is severely high ...

The shares of each company came under pressure following the release of clinical data on the efficacy of glucagon-like-peptide ... BPL-003 is an intranasal formulation of mebufotenin benzoate ...

The Food and Drug Administration (FDA) has expanded the approval of Baqsimi (glucagon) nasal powder to include the treatment of severe hypoglycemia in patients aged 1 year and older with diabetes.